LRRK2G2019S变异与在促炎环境下帕金森病人类髓状细胞的转录性变化有关
Elisa Navarro1,2,3,4,5,6,7, Anastasia G Efthymiou1,2,3, Madison Parks1,2,3,4
1Nash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
bioRxiv : the preprint server for biology
|June 10, 2024
概括
富含白的重复激酶2 (LRRK2) 中的G2019S突变影响了帕金森病的风险. 这项研究表明,这种突变会改变免疫细胞的基因表达和功能,特别是在脂质代谢和细胞化中.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病的遗传学
- 细胞和分子生物学 细胞和分子生物学
背景情况:
- LRRK2中的G2019S突变是帕金森病 (PD) 的重要遗传风险因素.
- LRRK2在先天性免疫细胞中高度表达,这表明它在PD中的神经炎症中发挥了作用.
- 免疫细胞,包括微质细胞和单细胞,都与PD的发病有关.
研究的目的:
- 研究LRRK2 G2019S突变对转录组和微质细胞和单细胞细胞的功能的影响.
- 了解这种突变如何影响髓状细胞对炎症刺激的反应.
主要方法:
- 产生了同位素人类诱导的微质细胞 (iMGLs) 和患者衍生的具有G2019S突变的单细胞的大规模转录形状.
- 在基线条件下和IFNγ和LPS刺激后分析的细胞.
- 评估功能差异,包括细胞容量.
主要成果:
- G2019S突变显著改变了髓状细胞的转录组.
- 在iMGLs中观察到脂质代谢和解体通路基因的升调,与髓碎片的细胞增多相关.
- 细胞周期基因的调节失调,特别是E2F4 regulon的下调,被确定.
- 人类单细胞转录体也显示了脂质代谢相关基因的变化.
结论:
- LRRK2 G2019S突变对髓状细胞转录组和功能产生了深刻的影响.
- 促炎症状况加剧了这些变化,突显了突变在帕金森病中免疫失调中的作用.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
相关概念视频
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
01:15Parkinson's Disease: Overview
527
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
527